The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in PregnancyGeoffrey C. Nguyen, William G. Paterson, Cynthia H. Seow et al.|Gastroenterology|2015Cited by 478
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Michael M.P. J.A. van der Voorn et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratificationJeanine Arkenbosch, Annemarie C. de Vries, Evelien Beelen et al.|Journal of Crohn s and Colitis|2022Cited by 3
P190 Identification of clinical risk factors for postoperative endoscopic recurrence in Crohn’s disease: a prospective, multicenter cohort studyM Bak, Andrica de Vries, Evelien Beelen et al.|Journal of Crohn s and Colitis|2024Cited by 1
P388 Prediction model to safely CEASE anti-TNF therapy in Crohn’s disease: validation of a predictive diagnostic tool for the cessation of anti-TNF treatment in CD in a Dutch populationSebastiaan ten Bokkel Huinink, Andrica de Vries, D. de Jong et al.|Journal of Crohn s and Colitis|2020Cited by 0